Phapros Tbk PT Asset Resilience Ratio

Latest as of December 2025: 5.12%

Phapros Tbk PT asset resilience ratio. Phapros Tbk PT (PEHA) has an Asset Resilience Ratio of 5.12% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PEHA cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rp71.02 Billion
≈ $4.16 Million USD Cash + Short-term Investments

Total Assets

Rp1.39 Trillion
≈ $81.28 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Phapros Tbk PT (2011–2025)

Asset resilience ratio of Phapros Tbk PT from 2011 to 2025. This chart shows how Phapros Tbk PT's Asset Resilience Ratio has changed over time. Read total liabilities of Phapros Tbk PT for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Phapros Tbk PT's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Phapros Tbk PT.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rp70.40 Billion 5.08%
Short-term Investments Rp620.61 Million 0.04%
Total Liquid Assets Rp71.02 Billion 5.12%

Asset Resilience Insights

  • Limited Liquidity: Phapros Tbk PT maintains only 5.12% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Phapros Tbk PT Industry Peers by Asset Resilience Ratio

Compare Phapros Tbk PT's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
Drug Manufacturers - Specialty & Generic 29.37%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.01%
Shenzhen Chipscreen Biosciences Co
SHG:688321
Drug Manufacturers - Specialty & Generic 5.10%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829
Drug Manufacturers - Specialty & Generic 0.00%

Phapros Tbk PT Asset Resilience Ratio by Year (2011–2025)

Phapros Tbk PT asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for Phapros Tbk PT.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 5.08% Rp70.40 Billion
≈ $4.13 Million
Rp1.39 Trillion
≈ $81.28 Million
+5.05pp
2024-12-31 0.03% Rp400.00 Million
≈ $23.44K
Rp1.43 Trillion
≈ $83.79 Million
-0.16pp
2023-12-31 0.19% Rp3.40 Billion
≈ $199.23K
Rp1.77 Trillion
≈ $103.47 Million
+4.47pp
2022-12-31 -4.28% Rp-77.25 Billion
≈ $-4.53 Million
Rp1.81 Trillion
≈ $105.84 Million
-0.08pp
2021-12-31 -4.20% Rp-77.15 Billion
≈ $-4.52 Million
Rp1.84 Trillion
≈ $107.73 Million
-2.84pp
2020-12-31 -1.36% Rp-26.01 Billion
≈ $-1.52 Million
Rp1.92 Trillion
≈ $112.27 Million
-3.89pp
2019-12-31 2.54% Rp53.18 Billion
≈ $3.12 Million
Rp2.10 Trillion
≈ $122.86 Million
+2.64pp
2018-12-31 -0.11% Rp-1.97 Billion
≈ $-115.14K
Rp1.87 Trillion
≈ $109.50 Million
-11.18pp
2017-12-31 11.08% Rp130.25 Billion
≈ $7.63 Million
Rp1.18 Trillion
≈ $68.91 Million
+11.66pp
2013-12-31 -0.59% Rp-3.76 Billion
≈ $-220.58K
Rp643.09 Billion
≈ $37.68 Million
+0.07pp
2012-12-31 -0.66% Rp-3.66 Billion
≈ $-214.69K
Rp558.64 Billion
≈ $32.73 Million
+0.19pp
2011-12-31 -0.84% Rp-3.90 Billion
≈ $-228.29K
Rp462.59 Billion
≈ $27.11 Million
--
pp = percentage points

About Phapros Tbk PT

JK:PEHA Indonesia Drug Manufacturers - Specialty & Generic
Market Cap
$12.99 Million
Rp221.76 Billion IDR
Market Cap Rank
#26234 Global
#567 in Indonesia
Share Price
Rp264.00
Change (1 day)
+0.00%
52-Week Range
Rp214.00 - Rp384.00
All Time High
Rp2996.89
About

PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides … Read more